Birth control pill interaction study for new hepatitis c drug
NCT ID NCT07272889
First seen Jan 10, 2026 · Last updated May 15, 2026 · Updated 27 times
Summary
This study looked at whether taking an experimental hepatitis C medication (bemnifosbuvir/ruzasvir) changes how a common birth control pill (ethinyl estradiol/levonorgestrel) works in the body. It involved 24 healthy women who were past menopause or surgically sterile. The goal was to measure drug levels in the blood to check for interactions, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER STUDY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Atea Study Site
Québec, Montreal, Canada
Conditions
Explore the condition pages connected to this study.